Research Article
Laboratory Investigation (2005) 85, 397–407, advance online publication, 20 December 2004; doi:10.1038/labinvest.3700225
Matrix metalloproteinase pattern in celiac duodenal mucosa
Rachele Ciccocioppo1, Antonio Di Sabatino1, Michael Bauer2, Daniela N Della Riccia3, Francesca Bizzini3, Federico Biagi1, Maria G Cifone3, Gino R Corazza1 and Detlef Schuppan2
- 1Gastroenterology Unit, IRCCS Policlinico San Matteo, University of Pavia, Italy
- 2Department of Medicine I, Friedrich-Alexander University of Erlangen-Nuremberg, Germany
- 3Department of Experimental Medicine, University of L'Aquila, Italy
Correspondence: Professor GR Corazza, MD, Gastroenterology Unit, IRCCS Policlinico San Matteo, Piazzale Golgi, 5, 27100 Pavia, Italy. E-mail: gr.corazza@smatteo.pv.it
Received 2 August 2004; Revised 20 October 2004; Accepted 23 October 2004; Published online 20 December 2004.
Abstract
Matrix metalloproteinases (MMPs) are a family of endopeptidases playing a key role in tissue remodelling in both physiological and pathological conditions. Since little information is available about their role in celiac disease (CD), our aims were to quantify their expression/activity and to investigate their relation to proinflammatory cytokines in this condition. Duodenal biopsies from untreated, treated celiac patients and controls were used to quantify the expression of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12, MMP-14, their inhibitor TIMP-1, IFN-
and TNF-
by using real-time reverse transcription-polymerase chain reaction and the gelatin/casein/elastin activities by gel zymography, and to isolate lamina propria mononuclear cells (LPMCs). These cells and myofibroblasts isolated from jejunal specimens were incubated in the absence or presence of IFN-
and TNF-
. MMP-1 and MMP-12 mRNA levels were significantly increased in active CD compared to treated (P<0.01 and P<0.0005, respectively) and normal mucosa (P<0.01 and P<0.0005, respectively), and this was paralleled by an upregulation of caseinolytic and elastolytic activities. Furthermore, MMP-12 levels significantly (P<0.05) correlated with those of IFN-
and the degree of villous flattening. MMP-2 turned out to be significantly (P<0.05) reduced in untreated and treated celiacs compared to controls. In active CD, transcripts of TIMP-1 were higher than in treated and controls (P<0.005 and P<0.05, respectively), such as those of IFN-
(P<0.05), whereas TNF-
levels were suppressed (P=0.0001). In physiological condition, myofibroblasts represent the main source of MMP-2, whereas LPMCs produce almost all MMPs only after cytokine stimulation. Conversely, cells isolated from active patients constitutively express MMPs without any increase after cytokine stimulation, while those from treated patients are in a resting condition. In conclusion, our results show the presence of a peculiar MMP pattern in active CD strongly dominated by MMP-12, correlating either with IFN-
or the degree of mucosal damage.
Keywords:
cytokines, celiac disease, extracellular matrix, metalloproteinases, mucosal damage
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Exposing gliadin as a tasty food for lymphocytes
Nature Medicine News and Views (01 Jun 1998)
Transglutaminase, gluten and celiac disease: Food for thought
Nature Medicine News and Views (01 Jul 1997)
RESEARCH
Journal of Cerebral Blood Flow & Metabolism Original Article
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins
Nature Immunology Article (01 Jun 2001)

